NCM
HCA icon

Narwhal Capital Management’s HCA Healthcare HCA Stock Holding History

Narwhal Capital Management’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Sell
6,813
-4,566
-40% -$1.93M 0.18% 77
2026
Q1 		$5.38M Sell
11,379
-1,864
-14% -$938K 0.4% 59
2025
Q4 		$6.18M Buy
13,243
+6,205
+88% +$2.88M 0.45% 50
2025
Q3 		$3M Sell
7,038
-297
-4% -$115K 0.22% 72
2025
Q2 		$2.81M Sell
7,335
-3,115
-30% -$1.12M 0.23% 79
2025
Q1 		$3.61M Sell
10,450
-9,056
-46% -$2.91M 0.32% 66
2024
Q4 		$5.85M Sell
19,506
-3,714
-16% -$1.3M 0.52% 45
2024
Q3 		$9.44M Sell
23,220
-4,058
-15% -$1.49M 0.85% 31
2024
Q2 		$8.76M Sell
27,278
-7,143
-21% -$2.32M 0.83% 34
2024
Q1 		$11.5M Buy
34,421
+3,663
+12% +$1.12M 1.12% 24
2023
Q4 		$8.33M Buy
30,758
+5,275
+21% +$1.3M 0.91% 33
2023
Q3 		$6.27M Sell
25,483
-2,216
-8% -$606K 0.77% 39
2023
Q2 		$8.41M Sell
27,699
-10,601
-28% -$2.95M 0.99% 30
2023
Q1 		$10.1M Sell
38,300
-3,090
-7% -$785K 1.26% 24
2022
Q4 		$9.93M Buy
41,390
+1,814
+5% +$406K 1.32% 24
2022
Q3 		$7.27M Buy
39,576
+7,751
+24% +$1.54M 1.05% 30
2022
Q2 		$5.35M Buy
31,825
+11,633
+58% +$2.5M 0.73% 43
2022
Q1 		$5.06M Buy
20,192
+2,309
+13% +$580K 0.59% 49
2021
Q4 		$4.59M Buy
17,883
+12,010
+204% +$2.94M 0.52% 53
2021
Q3 		$1.43M Buy
5,873
+1,325
+29% +$324K 0.18% 82
2021
Q2 		$940K Buy
4,548
+817
+22% +$167K 0.12% 93
2021
Q1 		$703K Buy
3,731
+139
+4% +$24.5K 0.1% 102
2020
Q4 		$591K Buy
3,592
+1,531
+74% +$224K 0.08% 105
2020
Q3 		$257K Sell
2,061
-2,060
-50% -$255K 0.04% 122
2020
Q2 		$400K Buy
4,121
+88
+2% +$9.15K 0.07% 108
2020
Q1 		$362K Sell
4,033
-3,028
-43% -$392K 0.08% 101
2019
Q4 		$1.04M Hold
7,061
– – 0.19% 87
2019
Q3 		$850K Hold
7,061
– – 0.17% 92
2019
Q2 		$954K Sell
7,061
-35
-0.5% -$4.42K 0.2% 89
2019
Q1 		$925K Buy
7,096
+156
+2% +$21K 0.2% 91
2018
Q4 		$864K Hold
6,940
– – 0.21% 94
2018
Q3 		$965K Hold
6,940
– – 0.21% 98
2018
Q2 		$712K Sell
6,940
-2,000
-22% -$202K 0.17% 106
2018
Q1 		$867K Hold
8,940
– – 0.2% 106
2017
Q4 		$785K Sell
8,940
-21,915
-71% -$1.76M 0.18% 107
2017
Q3 		$2.46M Hold
30,855
– – 0.61% 58
2017
Q2 		$2.69M Sell
30,855
-5,700
-16% -$482K 0.7% 50
2017
Q1 		$3.25M Sell
36,555
-4,550
-11% -$379K 0.91% 35
2016
Q4 		$3.04M Buy
41,105
+1,775
+5% +$133K 0.92% 35
2016
Q3 		$2.98M Sell
39,330
-400
-1% -$30.6K 0.93% 32
2016
Q2 		$3.06M Sell
39,730
-1,400
-3% -$111K 0.96% 31
2016
Q1 		$3.21M Sell
41,130
-175
-0.4% -$12.2K 1.05% 26
2015
Q4 		$2.79M Sell
41,305
-1,000
-2% -$69.8K 0.97% 34
2015
Q3 		$3.27M Buy
42,305
+1,695
+4% +$150K 1.22% 21
2015
Q2 		$3.68M Buy
40,610
+525
+1% +$42.1K 1.34% 19
2015
Q1 		$3.02M Buy
40,085
+2,425
+6% +$174K 1.1% 25
2014
Q4 		$2.76M Buy
37,660
+8,585
+30% +$603K 1.07% 28
2014
Q3 		$2.05M Buy
29,075
+100
+0.3% +$6.61K 0.82% 42
2014
Q2 		$1.63M Buy
28,975
+5,150
+22% +$272K 0.63% 61
2014
Q1 		$1.25M Buy
23,825
+11,350
+91% +$565K 0.52% 76
2013
Q4 		$595K Buy
+12,475
New +$577K 0.25% 109

Other funds holding HCA

MC
Metropolis Capital Amersham, United Kingdom $3.45B AUM 1.26% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ET
Equitable Trust Nashville, Tennessee $2.4B AUM 30.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SJL
Shayne & Jacobs LLC Nashville, Tennessee $337M AUM 19.04% 1-Year Est. Return

Narwhal Capital Management's HCA Position: Q2 2026 in Review

Narwhal Capital Management reduced its HCA Healthcare (HCA) stake by 40% in Q2 2026, selling an estimated $1.93M and leaving 6,813 shares worth $2.66M. The position accounts for 0.18% of the portfolio, ranked #77.

Narwhal Capital Management first reported a position in HCA in Q4 2013 and has held it in 51 quarters since. The position peaked at $11.5M in Q1 2024. 342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Narwhal Capital Management held 6,813 shares of HCA Healthcare worth $2.66M as of Q2 2026.
  • Narwhal Capital Management sold 4,566 HCA Healthcare shares in Q2 2026, an estimated $1.93M.
  • HCA Healthcare made up 0.18% of Narwhal Capital Management's portfolio in Q2 2026, its #77 holding.
  • Narwhal Capital Management first reported a position in HCA Healthcare in Q4 2013 and has held it in 51 quarters since.
  • Narwhal Capital Management's HCA Healthcare position peaked at $11.5M in Q1 2024.
  • 342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Narwhal Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.